Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
Open accessThe DOI matches its Crossref record; 66 of the 69 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia refers to a group of progressive neurodegenerative syndromes usually caused by the accumulation of pathological tau or TDP-43 proteins. The effects of these proteins in the brain are complex, and each can present with several different clinical syndromes. Clinical efficacy trials of drugs targeting these proteins must use endpoints that are meaningful to all participants despite the variability in symptoms across patients. There are many candidate clinical measures, including neuropsychological scores and functional measures. Brain imaging is another potentially attractive outcome that can be precisely quantified and provides evidence of disease modification. Most imaging studies in frontotemporal dementia have been cross-sectional, and few have compared longitudinal changes in cortical volume with changes in other measures such as perfusion and white matter integrity. The current study characterized longitudinal changes in 161 patients with three frontotemporal dementia syndromes: behavioural variant frontotemporal dementia (n = 77) and the semantic (n = 45) and non-fluent (n = 39) variants of primary progressive aphasia. Visits included comprehensive neuropsychological and functional assessment, structural MRI (3 T), diffusion tensor imaging, and arterial spin labelled perfusion imaging. The goal was to identify measures that are appropriate as clinical trial outcomes for each group, as well as those that might be appropriate for trials that would include more than one of these groups. Linear mixed effects models were used to estimate changes in each measure, and to examine the correlation between imaging and clinical changes. Sample sizes were estimated based on the observed effects for theoretical clinical trials using bootstrapping techniques to provide 95% confidence intervals for these estimates. Declines in functional and neuropsychological measures, as well as frontal and temporal cortical volumes and white matter microstructure were detected in all groups. Imaging changes were statistically significantly correlated with, and explained a substantial portion of variance in, the change in most clinical measures. Perfusion and diffusion tensor imaging accounted for variation in clinical decline beyond volume alone. Sample size estimates for atrophy and diffusion imaging were comparable to clinical measures. Corpus callosal fractional anisotropy led to the lowest sample size estimates for all three syndromes. These findings provide further guidance on selection of trial endpoints for studies in frontotemporal dementia and support the use of neuroimaging, particularly structural and diffusion weighted imaging, as biomarkers. Diffusion and perfusion imaging appear to offer additional utility for explaining clinical change beyond the variance explained by volume alone, arguing for considering multimodal imaging in treatment trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the clinical diagnosis of each frontotemporal dementia (FTD) variant requires high levels of expertise and multidisciplinary teams to distinguish among subtle phenotypes with similar underlying physiopathological processes (Bejanin et al., 2020; Staffaroni et al., 2019; Zetterberg et al., 2019).”
From Multiclass characterization of frontotemporal dementia variants via multimodal brain network computational inference (2023) · cites this paper as Staffaroni et al., 2019
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Tuberous sclerosis–associated neuropsychiatric disorders symptoms overlap with clinical criteria for frontotemporal dementia, yet the association between the 2 has not been explored.”
From Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia (2020) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationKaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Peabody Picture Vocabulary Test
Campbell, J. M., & Dommestrup, A. K. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0649 · Cited by 3,787
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Mapelli, D., Di Rosa, E., Nocita, R., & Sava, D. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353457 · Cited by 3,453
Measurement of Functional Activities in Older Adults in the Community
Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Chance, J. M., & Filos, S. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.3.323 · Cited by 2,972
Appelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
The clinical global impressions scale: applying a research tool in clinical practice.
Busner, J., & Targum, S. D. (2007) · PubMed · Cited by 2,759
Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., van Swieten, J. C., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,046
Cognition and anatomy in three variants of primary progressive aphasia
Gorno‐Tempini, M. L., Dronkers, N. F., Rankin, K. P., Ogar, J. M., Phengrasamy, L., Rosen, H. J., Johnson, J. K., Weiner, M. W., & Miller, B. L. (2004) · Annals of Neurology · doi:10.1002/ana.10825 · Cited by 1,625
Self-citationAmyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Wechsler Adult Intelligence Scale
Szczepkowski, K. V., & Demakis, G. J. (2020) · Encyclopedia of Personality and Individual Differences · doi:10.1007/978-3-319-24612-3_1034 · Cited by 1,079
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
Hyman, D. M., Piha-Paul, S. A., Won, H., Rodon, J., Saura, C., Shapiro, G. I., Juric, D., Quinn, D. I., Moreno, V., Doger, B., et al. (2018) · Nature · doi:10.1038/nature25475 · Cited by 780
Biomarkers and surrogate endpoints in clinical trials
Fleming, T. R., & Powers, J. H. (2012) · Statistics in Medicine · doi:10.1002/sim.5403 · Cited by 544
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Implementing Genome-Driven Oncology
Hyman, D. M., Taylor, B. S., & Baselga, J. (2017) · Cell · doi:10.1016/j.cell.2016.12.015 · Cited by 503
Kramer, J. H., Jurik, J., Sha, S. J., Rankin, K. P., Rosen, H. J., Johnson, J. K., & Miller, B. L. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00002 · Cited by 502
Self-citationDevelopment of methodology for conducting clinical trials in frontotemporal lobar degeneration
Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. (2008) · Brain · doi:10.1093/brain/awn234 · Cited by 442
Self-citationSample size estimation in clinical trial
Sakpal, T. (2010) · Perspectives in Clinical Research · doi:10.4103/2229-3485.71856 · Cited by 425
Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information
Daly, E., Zaitchik, D., Copeland, M., Schmahmann, J., Gunther, J., & Albert, M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.675 · Cited by 360
Biomarkers and surrogate markers: An FDA perspective
Katz, R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.189 · Cited by 347
Primary Progressive Aphasia: Longitudinal Course, Neuropsychological Profile, and Language Features
Weintraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 310
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
Vandenberghe, R., Rinne, J. O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., Tuchman, M., Gass, A., Fiebach, J. B., Hill, D., et al. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0189-7 · Cited by 304
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI
Du, A. T., Jahng, G. H., Hayasaka, S., Kramer, J. H., Rosen, H. J., Gorno-Tempini, M. L., Rankin, K. P., Miller, B. L., Weiner, M. W., & Schuff, N. (2006) · Neurology · doi:10.1212/01.wnl.0000238163.71349.78 · Cited by 288
Self-citationBoxer, A. L., Knopman, D. S., Kaufer, D. I., Grossman, M., Onyike, C., Graf-Radford, N., Mendez, M., Kerwin, D., Lerner, A., Wu, C.-K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70320-4 · Cited by 228
Self-citationKhan, B. K., Yokoyama, J. S., Takada, L. T., Sha, S. J., Rutherford, N. J., Fong, J. C., Karydas, A. M., Wu, T., Ketelle, R. S., Baker, M. C., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301883 · Cited by 185
Self-citationNetwork degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
Lee, S. E., Sias, A. C., Mandelli, M. L., Brown, J. A., Brown, A. B., Khazenzon, A. M., Vidovszky, A. A., Zanto, T. P., Karydas, A. M., Pribadi, M., et al. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.12.006 · Cited by 165
Self-citationRanasinghe, K. G., Rankin, K. P., Pressman, P. S., Perry, D. C., Lobach, I. V., Seeley, W. W., Coppola, G., Karydas, A. M., Grinberg, L. T., Shany-Ur, T., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2016 · Cited by 151
Self-citationTherapy and clinical trials in frontotemporal dementia: past, present, and future
Tsai, R. M., & Boxer, A. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13640 · Cited by 143
Self-citationMapping Neurodegenerative Disease Onset and Progression
Seeley, W. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023622 · Cited by 104
Self-citationLongitudinal diffusion tensor imaging in frontotemporal dementia
Mahoney, C. J., Simpson, I. J. A., Nicholas, J. M., Fletcher, P. D., Downey, L. E., Golden, H. L., Clark, C. N., Schmitz, N., Rohrer, J. D., Schott, J. M., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24296 · Cited by 101
Asymmetry of cortical decline in subtypes of primary progressive aphasia
Rogalski, E., Cobia, D., Martersteck, A., Rademaker, A., Wieneke, C., Weintraub, S., & Mesulam, M.-M. (2014) · Neurology · doi:10.1212/wnl.0000000000000824 · Cited by 101
Vitali, P., Migliaccio, R., Agosta, F., Rosen, H., & Geschwind, M. (2008) · Seminars in Neurology · doi:10.1055/s-0028-1083695 · Cited by 98
Self-citationInitiative, T. A. D. N., Zu, C., Jie, B., Liu, M., Chen, S., Shen, D., & Zhang, D. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9480-7 · Cited by 95
Zhang, Y., Tartaglia, M. C., Schuff, N., Chiang, G. C., Ching, C., Rosen, H. J., Gorno-Tempini, M. L., Miller, B. L., & Weiner, M. W. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121156 · Cited by 94
Self-citationStaffaroni, A., Elahi, F., McDermott, D., Marton, K., Karageorgiou, E., Sacco, S., Paoletti, M., Caverzasi, E., Hess, C., Rosen, H., et al. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608808 · Cited by 91
Self-citationLam, B. Y. K., Halliday, G. M., Irish, M., Hodges, J. R., & Piguet, O. (2014) · Human Brain Mapping · doi:10.1002/hbm.22420 · Cited by 90
Ramanan, S., Bertoux, M., Flanagan, E., Irish, M., Piguet, O., Hodges, J. R., & Hornberger, M. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000837 · Cited by 90
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year
Knopman, D. S., Jack, C. R., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a71236 · Cited by 85
Self-citationMeasuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study
Gordon, E., Rohrer, J. D., Kim, L. G., Omar, R., Rossor, M. N., Fox, N. C., & Warren, J. D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d1a879 · Cited by 70
Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD
Tosun, D., Schuff, N., Rabinovici, G. D., Ayakta, N., Miller, B. L., Jagust, W., Kramer, J., Weiner, M. M., & Rosen, H. J. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.330 · Cited by 62
Self-citationEmerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
Panza, F., Seripa, D., Solfrizzi, V., Imbimbo, B. P., Lozupone, M., Leo, A., Sardone, R., Gagliardi, G., Lofano, L., Creanza, B. C., et al. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1241232 · Cited by 59
Santillo, A. F., Mårtensson, J., Lindberg, O., Nilsson, M., Manzouri, A., Landqvist Waldö, M., van Westen, D., Wahlund, L.-O., Lätt, J., & Nilsson, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066932 · Cited by 57
Simone, A. N., Bedard, A., Marks, D. J., & Halperin, J. M. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617715001010 · Cited by 57
Dopper, E. G. P., Chalos, V., Ghariq, E., den Heijer, T., Hafkemeijer, A., Jiskoot, L. C., de Koning, I., Seelaar, H., van Minkelen, R., van Osch, M. J. P., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.08.001 · Cited by 57
Tu, S., Leyton, C. E., Hodges, J. R., Piguet, O., & Hornberger, M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150626 · Cited by 56
Boxer, A. L., Gold, M., Huey, E., Hu, W. T., Rosen, H., Kramer, J., Gao, F., Burton, E. A., Chow, T., Kao, A., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.03.003 · Cited by 54
Self-citationPossin, K. L., Chester, S. K., Laluz, V., Bostrom, A., Rosen, H. J., Miller, B. L., & Kramer, J. H. (2012) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712000604 · Cited by 47
Self-citationMiller, B., & Perry, D. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1359316 · Cited by 44
Self-citationLongitudinal memory profiles in behavioral-variant frontotemporal dementia and Alzheimer’s disease
Schubert, S., Leyton, C. E., Hodges, J. R., & Piguet, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150802 · Cited by 37
Optimal composite scores for longitudinal clinical trials under the linear mixed effects model
Ard, M. C., Raghavan, N., & Edland, S. D. (2015) · Pharmaceutical Statistics · doi:10.1002/pst.1701 · Cited by 33
Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration
Pankov, A., Binney, R. J., Staffaroni, A. M., Kornak, J., Attygalle, S., Schuff, N., Weiner, M. W., Kramer, J. H., Dickerson, B. C., Miller, B. L., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.08.002 · Cited by 24
Self-citationLee, D., Park, J. W., Park, S.-H., & Hong, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0112045 · Cited by 23
Binney, R. J., Pankov, A., Marx, G., He, X., McKenna, F., Staffaroni, A. M., Kornak, J., Attygalle, S., Boxer, A. L., Schuff, N., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.675 · Cited by 21
Self-citationPerry, D. C., & Rosen, H. J. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch5 · Cited by 10
Self-citationIn Vivo Correlates of Pathological Diagnosis in Primary Progressive Aphasia (P4.009)
Spinelli, E. G., Mandelli, M. L., Santos‐Santos, M., Vinceti, G., Watson, C., Agosta, F., Filippi, M., Miller, B. L., Seeley, W., & Tempini, M. L. G. (2016) · Neurology · doi:10.1212/wnl.86.16_supplement.p4.009 · Cited by 2
Self-citation
Research works printed but not linked: 4
- Delis, 2001, Delis-Kaplan Executive Function System (DKEFS): Examiner’s manual
- Delis, 2000, California Verbal Learning Test - second edition. Adult version. Manual
- Howard, 1992, Pyramids and palm trees: A test of semantic access from pictures and words
- Schwab, 1969, Projection technique for evaluating surgery in Parkinson’s disease
Cited by
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01942-9 · Cited by 140
Self-citationPreventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Benatar, M. G., Wuu, J., McHutchison, C. A., Postuma, R. B., Boeve, B. F., Petersen, R. C., Ross, C. A., Rosen, H. J., Arias, J. J., Fradette, S., et al. (2021) · Brain · doi:10.1093/brain/awab404 · Cited by 133
“95 Among the many MRI measures evaluated in cross-sectional and longitudinal studies in FTLD, 96,97–103 volumetric MRI has shown the most promise in characterizing changes during the pre-symptomatic phase of f-FTLD (FTLD-CDR score = 0), with the topography of changes depending on the mutated gene.”
Self-citationNetwork localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer’s disease
Tetreault, A. M., Phan, T. X., Orlando, D., Lyu, I., Kang, H., Landman, B. A., Darby, R. R., & Initiative, O. B. O. A. D. N. (2020) · Brain · doi:10.1093/brain/awaa058 · Cited by 130
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
Henry, M. L., Hubbard, H. I., Grasso, S. M., Dial, H. R., Beeson, P. M., Miller, B. L., & Gorno-Tempini, M. L. (2019) · Journal of Speech, Language, and Hearing Research · doi:10.1044/2018_jslhr-l-18-0144 · Cited by 118
Self-citation
Metadata
- Authors
- Staffaroni, A. M., Ljubenkov, P. A., Kornak, J., Cobigo, Y., Datta, S., Marx, G., Walters, S. M., Chiang, K., Olney, N., Elahi, F. M., Knopman, D. S., Dickerson, B. C., Boeve, B. F., Gorno-Tempini, M. L., Spina, S., Grinberg, L. T., Seeley, W. W., Miller, B. L., Kramer, J. H., Boxer, A. L., & Rosen, H. J.
- Affiliations
- University of California, San Francisco (US)
- Mayo Clinic (US)
- Harvard University (US)
- Department of Neurology, Memory and Aging Center, University of California at San Francisco (UCSF), San Francisco, CA, USA
- Universidade de São Paulo (BR)
- Corresponding author
- Staffaroni, Adam M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-29
- Volume
- 142
- Issue
- 2
- Pages
- 443-459
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6351779
- OpenAlex
- W2912954741
- Cited by
- 105
- References
- 69
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 10 · 2023: 14 · 2022: 15 · 2021: 19 · 2020: 12 · 2019: 8
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (AG045333, AG045390, AG032306, AG019724, AG023501)
- Hillblom Network
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal dementia, clinical trial endpoints, longitudinal neuroimaging, multimodal imaging, diffusion tensor imaging, cortical atrophy, white matter microstructure, behavioral variant frontotemporal dementia, primary progressive aphasia, semantic variant, neuropsychological decline, functional decline, sample size determination, biomarkers, tau protein, TDP-43
- MeSH terms
- Aged, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Endpoint Determination, Diffusion Tensor Imaging, Frontotemporal Dementia, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.